Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.
Telix Pharmaceuticals is seeking a Global Clinical Lead to support the international rollout of their prostate cancer imaging agent and the advancement of late-stage products in oncology and rare diseases. This role involves the end-to-end clinical development, ensuring alignment with commercial objectives, and partnering with various teams to advance the portfolio. The ideal candidate will have a deep understanding of the clinical landscape and the ability to translate scientific insights into actionable development plans.
Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.
Ultragenyx